Meridabio - About the company
Meridabio is an acquired company based in Cambridge (United States), founded in 2019. It operates as a Developer of targeted therapies for autoimmune and allergic disorders. Meridabio has raised $121M in funding from Bain Capital Life Sciences. The company has 434 active competitors, including 138 funded and 118 that have exited. Its top competitors include companies like BeiGene, Biogen and argenx.
Company Details
Developer of targeted therapies for autoimmune and allergic disorders. It focuses on creating specific therapies to offer relief for patients. The company's platform aims to target the pathogenic drivers of antibody-driven diseases. It develops therapeutics through preclinical and clinical phases.
Key Metrics
Founded Year
2019
Location
Cambridge, United States
Stage
Acquired
Total Funding
$121M in 1 round
Latest Funding Round
Investors
Ranked
102nd among 434 active competitors
Exit Details
Acquired by Lilly (Aug 31, 2026)
Meridabio's acquisition details
Click here to take a look at Meridabio's acquisition in detail
Sign up to download Meridabio's company profile
Meridabio's funding and investors
Meridabio has raised a total funding of $121M over 1 round. Its latest funding round was a Series A round on Apr 09, 2025 for $*****. 4 investors participated in its latest round. Meridabio has 4 institutional investors.
Here is the list of recent funding rounds of Meridabio:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 09, 2025 | 7546640 | Series A | 5211242 | 3548750 | 7531261 | 4437910 |
Access funding benchmarks and valuations. Sign up today!View details of Meridabio's funding rounds and investors
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Meridabio's Competitors and alternates
Top competitors of Meridabio include BeiGene, Biogen and argenx. Here is the list of Top 10 competitors of Meridabio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 81/100 | |
2nd |  Biogen 1978, Cambridge (United States), Public | Developer of therapies for neurodegenerative and immunology disorders | $80M | 78/100 | |
3rd | Developer of antibody-based drugs to treat autoimmune diseases and cancer | $61.9M | 75/100 | ||
4th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
5th |  Abcellera Biologics 2012, Vancouver (Canada), Public | AI-enabled platform for antibodies discovery | $115M | 71/100 | |
6th | Developer of immunotherapeutics for the treatment of cancer and other diseases | $861M | 69/100 | ||
7th | ADMA Biologics 2005, Ramsey (United States), Public | Biopharmaceutical company innovating plasma-derived therapeutics for immune deficiencies and infectious diseases | $17.6M | 69/100 | |
8th |  Nimbus Therapeutics 2009, Cambridge (United States), Series F | Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 68/100 | |
9th | DBV Technologies 2002, Bagneux (France), Public | Developer of products for the treatment of various kinds of food allergies | $68.9M | 68/100 | |
10th | Theravance Biopharma 2001, Francisco (United States), Public | Developer of therapeutics for inflammatory and immunological diseases | - | 68/100 | |
102nd |  Meridabio 2019, Cambridge (United States), Acquired | Developer of targeted therapies for autoimmune and allergic disorders | $121M | 48/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Meridabio's competitors? Click here to see the top ones
Meridabio's Investments and acquisitions
Meridabio has made no investments or acquisitions yet.
Reports related to Meridabio
Here is the latest report on Meridabio's sector:
News related to Meridabio
Media has covered Meridabio for 1 event in last 1 year.
•
Eli Lilly to Acquire Merida Biosciences for $2.875 BillionContract Pharma•Aug 31, 2026•Meridabio, Lilly
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Meridabio
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
